Regenerative Medicine Offers Hope in Spinal Cord Injury
LONDON, May 11, 2008--Spinal cord injury (SCI) can be a catastrophic event for the individual. Traditionally, such injuries were viewed as permanent, irreversible neurological dysfunction, but over time research has shown some neuroplastic capability of the injured adult mammalian spinal cord. However, spontaneous functional recovery post-SCI is very modest. The peripheral nervous system (PNS), in contrast, is more robust in its capacity to regenerate following damage. Among the strategies to utilize elements of the PNS for regeneration of spinal cord, neurotization - the rerouting of intact peripheral nerves originating from spinal segments above the site of injury - has previously been studied and even applied clinically. Functional improvements after spinal cord injury (SCI) have been reported anecdotally following neurotization, but the underlying mechanisms have been poorly understood.
Using a rat model for spinal cord injury, Scientists at Harvard have shown significant functional recovery in neurotized animals versus controls. In addition to limited reinnervation in the target muscles, neurotized animals demonstrated multiparameters of neural reorganization in the distal lumbar cord. The findings are published in the May issue of Regenerative Medicine1 published by Future Medicine.
Dr Yang D. Teng, Director of the Laboratories of Spinal Cord injury and Neural Stem Cell Research at Harvard University together with colleagues from the USA, Turkey and Puerto Rico, hypothesized that neurotization-mediated recovery is primarily attributable to CNS neuroplasticity that therefore manifests optimal response during particular therapeutic windows. To test this hypothesis in the rat, they anastomosed the T12 intercostal nerve to the ipsilateral L3 nerve root 1-4 weeks after T13-L1 midline hemisection. Neurobehavioral function, as assessed by locomotion, extensor postural thrust and sciatic functional index of SCI rats receiving neurotization 7-10 days postinjury, recovered to levels close to non-SCI controls with neurotization only, beginning 3-5 weeks postanastomosis. Conversely, hindlimb deficits were unchanged in hemisected controls with sham neurotization or 4 weeks-delayed neurotization, and in rats that had undergone T13-L1 transection plus bilateral anastomoses.
In addition to limited reinnervation in the target muscles, neurotized SCI animals demonstrated multiparameters of neural reorganization in the distal lumbar cord, including enhanced proliferation of endogenous neural stem cells, increased immunoreactivity of serotonin and synaptophysin, and neurite growth/sprouting, suggesting that anastomosing functional nerves with the nerve stump emerging distal to the hemisection may help re-establish locomotor pattern generation in the dysfunctional spinal cord. This conclusion was validated by the fact that severance of the T13-contralateral cord abolished the postanastomosis functional recovery.
While the goal of reclaiming neural control of a denervated organ via neurotization should be further explored, the authors suggest that this procedure could be utilized for the purpose of enhancing neuroplasticity and activating the inherent regenerative and repair potential of the spinal cord. This approach may have additional synergistic potential when combined with other treatment strategies that also aim at inducing neuroplasticity in the injured spinal cord. Task-specific physical activities (e.g., locomotor training), electrical stimulation and NSC transplantation, for example, may be employed in conjunction with the surgical procedure to provide additional augmentation of the plastic potential of the spinal cord and facilitate reorganization of neural circuitry to achieve greater functional and anatomical improvement.
- ENDS -
For further information please contact:
Simon Boisseau, Sales and Marketing Manager, Future Science Group
T: +44 (0) 20 8371 6083 F: +44 (0) 20 8371 6099 E: s.boisseau@futuremedicine.com
1Functional recovery in T13-L1 hemisected rats resulting from peripheral nerve rerouting: role of central neuroplasticity. Y Teng et al
Regenerative Medicine, May 2008, Vol. 3, No. 3, Pages 309-327. (www.futuremedicine.com/toc/rme/3/3)
Note to editors:
The full text of the article is available on request from s.boisseau@futuremedicine.com
ABOUT FUTURE SCIENCE GROUP
The Future Science Group is an expanding group of independent publishing companies active in the field of scientific information and endeavor, including Expert Reviews Ltd (formerly known as Future Drugs Ltd) and Future Medicine Ltd. As a leading provider of products and services for the medical, science and business communities, we present the most important scientific breakthroughs in an accessible and evaluated format, while at the same time providing the scientific community with unique vehicles for disseminating forward-thinking research information and data. Future Medicine is a pioneer is publications associated with pharmcogenomics, personalized medicine and biomarker research. Complete listings of titles under the Expert Reviews and Future Medicine imprints are available at www.expert-reviews.com and www.futuremedicine.com respectively.
Posted: May 2008
